Development of antibacterial coating on silicone surface via chlorhexidine-loaded nanospheres

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 2, 2015, Pages 1-11

  Phuengkham, Hathaichanok ^a,b   Nasongkla, Norased ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

COATINGS; CONTROLLED DRUG DELIVERY; EMULSIFICATION; NANOSPHERES; SILICONES;

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL COATINGS; ARTIFICIAL URINES; CLINICAL APPLICATION; EMULSIFICATION-SOLVENT EVAPORATIONS; HOSPITAL ACQUIRED INFECTION; SILICONE SURFACES; URINARY TRACT INFECTIONS;

TARGETED DRUG DELIVERY;

CHLORHEXIDINE; NANOCOATING; NANOSPHERE; SILICONE; SOLVENT; ANTIINFECTIVE AGENT; BIOMATERIAL; DELAYED RELEASE FORMULATION; NANOCAPSULE; SILICONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; EMULSION; ESCHERICHIA COLI; IN VITRO STUDY; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SILASTIC TUBE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUSTAINED RELEASE PREPARATION; URINARY TRACT INFECTION; ADMINISTRATION AND DOSAGE; ADSORPTION; BACTERIAL PHENOMENA AND FUNCTIONS; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG EFFECTS; MICROBIOLOGY; PHYSIOLOGY; SYNTHESIS; ULTRASTRUCTURE; URINARY CATHETER;

ADSORPTION; ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DIFFUSION; NANOCAPSULES; NANOSPHERES; SILICONES; URINARY CATHETERS;

EID: 84922209291     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5418-2     Document Type: Article

References (34)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.
2. Apisarnthanarak A, Rutjanawech S, Wichansawakun S, Ratanabunjerdkul H, Patthranitima P, Thongphubeth K, et al. Initial inappropriate urinary catheters use in a tertiary-care center: incidence, risk factors, and outcomes. Am J Infect Control. 2007;35:594–9.
3. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28:68–75.
4. Reid G, Sharma S, Advikolanu K, Tieszer C, Martin RA, Bruce AW. Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters. Antimicrob Agents Chemother. 1994;38:1490–5.
5. Baveja JK, Willcox MDP, Hume EBH, Kumar N, Odell R, Poole-Warren LA. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials. 2004;25:5003–12.
6. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. J Antimicrob Chemother. 2008;61:651–7.
7. Phuengkham H, Teeranachaideekul V, Chulasiri M, Nasongkla N. Preparation and optimization of chlorophene-loaded nanospheres as controlled release antimicrobial delivery systems. Pharm Dev Technol. 2014. doi:10.3109/10837450.2014.959180.
8. Eke G, Kuzmina AM, Goreva AV, Shishatskaya EI, Hasirci N, Hasirci V. In vitro and transdermal penetration of PHBV micro/nanoparticles. J Mater Sci Mater Med. 2014;25:1471–81.
9. Durán N, De Oliveira AF, De Azevedo MMM. In vitro studies on the release of isoniazid incorporated in poly(ε-caprolactone). J Chemother. 2006;18:473–9.
10. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1–20.
11. Wu SC, Crews RT, Zelen C, Wrobel JS, Armstrong DG. Use of chlorhexidine-impregnated patch at pin site to reduce local morbidity: the ChIPPS Pilot Trial. Int Wound J. 2008;5:416–22.
12. Sheridan R, Doherty PJ, Gilchrist T, Healy D. The effect of antibacterial agents on the behaviour of cultured mammalian fibroblasts. J Mater Sci Mater Med. 1995;6:853–6.
13. Vandervoort J, Yoncheva K, Ludwig A. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chem Pharm Bull. 2004;52:1273–9.
14. Dierendonck M, De Koker S, De Rycke R, De Geest BG. Just spray it-LbL assembly enters a new age. Soft Matter. 2014;10:804–7.
15. Griffith DP, Musher DM, Itin C. Urease. The primary cause of infection induced urinary stones. Invest Urol. 1976;13:346–50.
16. Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, et al. Ciprofloxacin-encapsulated poly(d, l-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm. 2008;352:317–23.
17. Hughes MS, Moghadamian ES, Yin LY, Della Rocca GJ, Crist BD. Comparison of bulb syringe, pressurized pulsatile, and hydrosurgery debridement methods for removing bacteria from fracture implants. Orthopedics. 2012;35:e1046–50.
18. Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm. 2007;336:367–75.
19. Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release. 1999;57:259–68.
20. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147–79.
21. Chen MC, Liang HF, Chiu YL, Chang Y, Wei HJ, Sung HW. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J Control Release. 2005;108:178–89.
22. Shukla A, Fang JC, Puranam S, Hammond PT. Release of vancomycin from multilayer coated absorbent gelatin sponges. J Control Release. 2012;157:64–71.
23. Sanpo N, Ang SM, Cheang P, Khor KA. Antibacterial property of cold sprayed chitosan-cu/al coating. J Therm Spray Technol. 2009;18:600–8.
24. Holban AM, Grumezescu V, Grumezescu AM, Vasile BS, Truşcǎ R, Cristescu R, et al. Antimicrobial nanospheres thin coatings prepared by advanced pulsed laser technique. Beilstein J Nanotechnol. 2014;5:872–80.
25. Vasilev K, Cook J, Griesser HJ. Antibacterial surfaces for biomedical devices. Expert Rev Med Devices. 2009;6:553–67.
26. Johnson JR, Delavari P, Azar M. Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother. 1999;43:2990–5.
27. Hidalgo E, Dominguez C. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro. 2001;15:271–6.
28. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368:533–42.
29. Theerasilp M, Nasongkla N. Comparative studies of poly(ε-caprolactone) and poly(d, l-lactide) as core materials of polymeric micelles. J Microencapsul. 2013;30:390–7.
30. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006;6:2427–30.
31. Hernandez MD, Mansouri MD, Aslam S, Zeluff B, Darouiche RO. Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices. Infect Control Hosp Epidemiol. 2009;30:190–2.
32. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-aassociated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America. Clin Infect Dis. 2010;50:625–63.
33. Kowalczuk D, Ginalska G, Golus J. Characterization of the developed antimicrobial urological catheters. Int J Pharm. 2010;402:175–83.
34. Dellimore KH, Helyer AR, Franklin SE. A scoping review of important urinary catheter induced complications. J Mater Sci Mater Med. 2013;24:1825–35.